Literature DB >> 19812114

Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.

C Smestad1, L Sandvik, E G Celius.   

Abstract

There are few studies of long-term, cause-specific mortality in multiple sclerosis (MS) relating to population mortality. Our objective was to study survival, excess mortality and causes of death in a cohort of patients with a long history of MS. Patients living in Oslo with definite MS and onset during 1940-80 were included in 2006. Causes of death and mortality in the general population were obtained from the Cause of Death Registry of Statistics Norway. Of the 386 patients included in the study, 263 (68%) had died at inclusion. Median survival from onset was 35 years (Kaplan-Meier: 95% confidence interval 33-37). Primary progressive MS was associated with shorter survival, but mean age at death was similar for relapsing-remitting and primary progressive MS patients. The most frequent underlying cause of death was MS (50%), and infection was often registered as a contributory cause (56%). The all-cause standardized mortality ratio was 2.47. Excess mortality was most marked during the second decade after onset of MS. We conclude that infections are probably the main cause of death in patients with MS, but the frequency is underestimated due to misleading information on death certificates. Excess mortality in patients with MS first appeared during the second decade of the disease. Survival seems to be age-dependent rather than related to disease course.

Entities:  

Mesh:

Year:  2009        PMID: 19812114     DOI: 10.1177/1352458509107010

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  15 in total

1.  Multiple cause of death analysis in multiple sclerosis: A population-based study.

Authors:  Katharine Harding; Feng Zhu; Mohammed Alotaibi; Thomas Duggan; Helen Tremlett; Elaine Kingwell
Journal:  Neurology       Date:  2020-01-13       Impact factor: 9.910

Review 2.  Mortality in patients with multiple sclerosis.

Authors:  Antonio Scalfari; Volker Knappertz; Gary Cutter; Douglas S Goodin; Raymond Ashton; George C Ebers
Journal:  Neurology       Date:  2013-07-09       Impact factor: 9.910

3.  Association of multiple sclerosis with risk of mortality among a nationally representative sample of adults in the United States.

Authors:  Tyler J Titcomb; Wei Bao; Yang Du; Buyun Liu; Linda G Snetselaar; Terry L Wahls
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-05-30

4.  Predictors of Mortality in Veterans with Multiple Sclerosis in an Outpatient Clinic Setting.

Authors:  Meheroz H Rabadi; Christopher E Aston
Journal:  Int J MS Care       Date:  2017 Sep-Oct

5.  Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital Database.

Authors:  Frank R Ernst; Jennifer Pocoski; Gary Cutter; David W Kaufman; Dirk Pleimes
Journal:  Int J MS Care       Date:  2016 May-Jun

Review 6.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

7.  Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.

Authors:  Valeria Allizond; Sara Scutera; Silvia Rossi; Tiziana Musso; Cristina Crocillà; Paola Cavalla; Claudia Trebini; Elisa Simona Marra; Anna Maria Cuffini; Giuliana Banche
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

8.  Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.

Authors:  Emmanuelle Leray; Sandra Vukusic; Marc Debouverie; Michel Clanet; Bruno Brochet; Jérôme de Sèze; Hélène Zéphir; Gilles Defer; Christine Lebrun-Frenay; Thibault Moreau; Pierre Clavelou; Jean Pelletier; Eric Berger; Philippe Cabre; Jean-Philippe Camdessanché; Shoshannah Kalson-Ray; Christian Confavreux; Gilles Edan
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 9.  Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat.

Authors:  Mark Walterfang; Yin-Hsiu Chien; Jackie Imrie; Derren Rushton; Danielle Schubiger; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2012-10-06       Impact factor: 4.123

10.  Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.

Authors:  Douglas S Goodin; George C Ebers; Gary Cutter; Stuart D Cook; Timothy O'Donnell; Anthony T Reder; Marcelo Kremenchutzky; Joel Oger; Mark Rametta; Karola Beckmann; Volker Knappertz
Journal:  BMJ Open       Date:  2012-11-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.